Previously, we have shown that prostate cancer cells and triple-negative breast cancer (TNBC) cells overexpress LLT1 as a mechanism to evade NK-cell immunosurveillance [32,33,48]. This evidence concerns the gene CLEC2D and prostate carcinoma.